NUVB
USDNuvation Bio Inc. Class A Common Stock
$4.830-0.320 (-6.214%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$5.150
고가
$5.190
저가
$3.920
거래량
6.20M
기업 기본 정보
시가총액
1.7B
산업
생명공학
국가
United States
거래 통계
평균 거래량
7.11M
거래소
NYQ
통화
USD
52주 범위
저가 $1.54현재가 $4.830고가 $5.55
관련 뉴스
Analyst Upgrades
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
더 보기
BusinessWire
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
더 보기
BusinessWire
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
더 보기
